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Abstract
Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis (Mtb) that
is responsible for almost 1.5 million deaths per year. Sensing of mycobacteria by the host’s
immune system relies on different families of receptors present on innate immune cells.
Amongst them, several members of the Toll-like receptor (TLR) family are involved in the
activation of immune cells by mycobacteria, yet the in vivo contribution of individual TLRs
to the protective immune response remains controversial. On the contrary, MyD88, the
adaptor molecule for most TLRs, plays a non-redundant role in the protection against
tuberculosis and mice with a complete germline deletion of MyD88 succumb very early to
infection.  MyD88  is  expressed  in  both  immune  and  non-immune  cells,  but  it  is  not  clear
whether control of mycobacteria requires ubiquitous or cell-type specific MyD88 expression.
Therefore, using novel conditional switch-on mouse models, we aimed to investigate the
importance of MyD88 signalling in dendritic cells and macrophages for the induction of
protective effector mechanisms against mycobacterial infection. We conclude that specific
reactivation of MyD88 signalling in CD11c- or Lysozyme M-expressing myeloid cells during
Mycobacterium bovis BCG infection is sufficient to restore systemic and local inflammatory
cytokine production and to control pathogen burden.
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Introduction
Since the discovery of Mycobacterium tuberculosis (Mtb) as the causal agent of tuberculosis,
massive efforts have been made to understand the mechanisms underlying mycobacterial
persistence. Despite current knowledge, it is still unclear why the immune response is
insufficient to eradicate the bacteria and why almost 90% of Mtb-infected patients develop a
chronic silent infection [1].
Transmission of mycobacteria occurs mostly through the respiratory tract. Here, alveolar
macrophages and dendritic cells (DCs) that patrol the lungs capture mycobacteria by
phagocytosis using different receptors (e.g. DC-SIGN, mannose receptor, complement
receptor, scavenger receptor class A, pulmonary surfactant-associated protein A, surfactant
protein A, Fc receptor, CD14, CD40 and CD44) [2-4]. Exposure of macrophages and DCs to
mycobacteria or their products activates members of the TLR family, leading to a cascade of
events necessary for the orchestration of an inflammatory immune response [5-7]. For
example, CpG DNA sequences present in Mtb and Mycobacterium bovis BCG  can  be
recognised by TLR9 [8-10], whereas mycobacterial lipoprotein and lipoarabinomannan can
activate TLR2 [11, 12]. In addition, certain heat sensitive mycobacterial proteins can trigger
the endotoxin receptor TLR4 [13]. More recently, a role for TLR8 has been also proposed
[14]. In macrophages, early activation through TLRs is required for different effector
functions against mycobacterial infection, including inflammatory cytokine secretion,
production of ROS and reactive nitrogen intermediates (RNIs), maturation of the phagosome
and autophagy, a central process for mycobacterial killing [15, 16]. In contrast, the capacity of
DCs to kill BCG and Mtb is reduced compared to that of macrophages?[17-20]. DC activation
via TLRs and transport of mycobacterial products to the draining LNs is believed to be a
crucial mechanism to initiate adaptive immune responses [21, 22]. Indeed, depletion of DCs
using DTR-CD11c mice or altered DC migration to the LNs such as in plt mice, causes lower
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CD4+ T-cell activation and higher bacterial loads [23, 24]. In addition, DCs are an important
source of IL-12, a cytokine necessary for the induction of Th1 responses [25-27]. Thus,
although  TLR-induced  activation  of  macrophages  and  DCs  is  considered  as  one  of  the  key
effector mechanisms during the early phases of mycobacterial infection, little is known about
the relevance of these cells later during infection. DCs are believed to play a role during the
chronic phase of the disease by continuously sampling mycobacterial antigens to prime T
cells in the LNs, thus maintaining the balance between immunity and infection [28]. But
whether this mechanism requires continuous TLR signalling has not yet been investigated.
MyD88 is an adaptor protein originally described as a molecule involved in the differentiation
of  myeloid  cells  [29].  MyD88  mainly  transmits  signals  from  TLRs  and  most  IL-1  receptor
family members (e.g. IL-1, IL-18 and IL-33) [30, 31], but can also enhance IFN-?-mediated
macrophage functions [32]. MyD88 deficient mice (MyD88-/-) have an increased
susceptibility to virulent Mtb infection as well as to the non-virulent M. bovis BCG infection.
Indeed, MyD88 knockout mice infected with Mtb succumb  early  to  the  disease  [33-36],
whereas M. bovis BCG causes a chronic persistent infection of the lungs [37]. Similarly, mice
lacking components of the IL-1 axis (e.g. IL-1R, IL-1? or IL-1?) die early from Mtb infection
[35, 38, 39], whereas TLR2/4/9 triple knockout mice have normal bacterial burden and
immune responses [36]. Both MyD88 and IL-1R-deficient mycobacteria-infected mice have
elevated inflammatory infiltrates composed of myeloid cells [35, 40]. However, it is not clear
whether this excessive inflammatory response is an intrinsic defect of myeloid cells or
whether other cells are also involved. Using novel genetic mouse models, we show here that
despite a competent adaptive immune response, MyD88-/- mice possess an impaired capacity
to clear mycobacteria that leads to chronic infection. Conversely, mice that have reactivated
MyD88 signalling specifically in DCs or macrophages can control the infection similar to
wild type (wt) mice. Our results suggest that during M. bovis BCG infection, MyD88
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signalling in DCs and macrophages is essential to control bacterial burden and prevent
pathogen persistence.
Results
MyD88 deficient mice fail to clear mycobacterial infection
Germline deletion of MyD88 has been associated with higher bacterial burden in the lungs of
M. bovis BCG infected mice [37]. Similarly, here we observed that mice expressing a floxed
transcriptional  stop  element  between  exons  1  and  2  of  the  MyD88  gene  (MyD88OFF mice)
[41] failed to clear M. bovis BCG infection (Fig.1). Using the IVIS® Spectrum CT imager 5
days after infection with M. bovis BCG-expressing firefly luciferase (FFluc-BCG), we could
observe luciferase positive regions in the lungs, liver and spleen of MyD88OFF, but not in wt
mice (Fig.1A). Interestingly, these differences persisted even after longer periods of time
(Fig.1B). In addition, we also found higher bacterial burdens in the liver of MyD88OFF mice at
all time points evaluated and all infectious doses tested (Fig.1B, Supporting Information
Fig.4A). Thus, similar to MyD88-/- mice [37], MyD88OFF mice show an impaired capacity to
eliminate mycobacteria.
Innate and adaptive immune responses are required for protection against mycobacterial
infection
Sensing of pathogens by DCs and macrophages via TLRs and other PRRs is considered to be
essential to launch immune responses against infection. However, while macrophages are
primarily innate effector cells, DCs have rather an instructive function on the adaptive
immune system. Therefore, we aimed to determine whether the absence of MyD88 signalling
alters protective immune responses against mycobacteria by acting only via the adaptive
immune system or via innate functions. For this, we crossed MyD88-/- to Rag1 knockout mice
(Rag-/-),  lacking  B  and  T  cells,  and  infected  them  i.v.  with  2x106 CFUs M. bovis BCG.
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Twenty days after infection, MyD88-/- mice displayed increased bacterial burden in the lungs
and liver compared to wt mice (Fig.2A). However, Rag1 deficiency led to an even higher
number of bacteria in the lungs and liver than MyD88 deficiency (Fig.2A). Additionally,
bacterial load in the lungs and liver of MyD88-/- x Rag-/- double-deficient mice was
significantly higher than in wt, Rag-/- or MyD88-/- mice (Fig.2A), suggesting that protection
against M. bovis BCG infection depends on adaptive immune responses as well as on MyD88-
dependent activation of innate immune cells.
To gain further mechanistic insights, we next evaluated the pro-inflammatory cytokine profile
of wt, Rag-/- or MyD88-/- mice after M. bovis BCG infection. We focused on IL-12p40 and IL-
1?,  which are mainly produced by DCs and macrophages and serve therefore as markers of
innate inflammatory responses. In addition, we evaluated IFN-? production, which is mostly
produced by IL-12-induced Th1 cells and essential for the control of mycobacterial infection
[42,  43].  Consistent  with  the  presence  of  APCs  and  the  absence  of  T  cells  in  Rag-/- mice,
normal IL-12p40, but almost undetectable levels of IFN-? were measured in the lungs of these
mice (Fig.2B). Similarly, IFN-? was only detected in the serum of wt, but not Rag-/- mice
(Fig.2B). Yet, serum IL-12p40 levels were significantly reduced in Rag-/- mice compared to
wt controls, indicating that local secretion is not enough to sustain systemic IL-12p40 levels.
In MyD88-/- mice, IL-12p40 production was compromised both in the lungs and serum;
however lung IFN-? levels were significantly lower than in wt, but higher than in Rag-/- mice
(Fig.2B). Finally, compared to wt controls, IL-1? production was significantly reduced in
MyD88-/- and  to  a  lesser  extent  in  Rag-/- lungs, yet slightly increased in the serum of both
mice, suggesting the existence of different regulatory mechanisms for the control of systemic
and local IL-1? levels.
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MyD88 signalling in BMDCs is required for inflammatory cytokine production and Th1
polarisation
Production of inflammatory cytokines by DCs and macrophages is a prerequisite for
controlling mycobacterial infection, but its contribution to the initiation of adaptive immunity
to intracellular pathogens remains controversial. To determine whether MyD88 signalling in
DCs and/or macrophages is required for T helper cell differentiation, we crossed MyD88OFF
mice with mice expressing cre recombinase under the control of the CD11c (Itgax) promoter
or the Lysozyme M (LysM) promoter [44-46]. Cell-type specific expression of the cre
recombinase in the offspring of these mice, allows excision of the stop cassette and expression
of MyD88 exclusively in CD11c+ or LysM+ cells (Supporting Information Fig1). Since
CD11c  is  an  alpha  X  integrin  mostly  expressed  on  DCs  whereas  Lysozyme  M  is  an
antibacterial enzyme predominantly present in macrophage, we called these mice MyD88-
DCON?and MyD88- macrophageON mice, respectively.
Using these novel conditional switch-on mouse models, we first tested the capacity of bone
marrow-derived DCs (BMDCs) to produce inflammatory cytokines and induce Th1 and Th17
differentiation in vitro. BMDCs were infected with BCG at different MOI or treated with the
TLR9 ligand CpG-B, and cytokine production was evaluated intracellularly 5h later. As
expected, MyD88OFF BMDCs activated with CpG-B did not produce any IL-12p40, TNF? or
IL-1? (Fig.3A,  Supporting  Information  Fig2A).  Similarly,  only  a  small  percentage  of  the
MyD88OFF BMDCs produce IL-12p40, TNF? or IL-1? after infection with M. bovis BCG
compared to wt BMDCs. In contrast, MyD88-DCON BMDCs produced IL-12p40, TNF? or
IL-1? to  the  same levels  than  wt  BMDCs after  activation  with  CpG-B or  infection  with M.
bovis BCG, suggesting a complete reactivation of the MyD88 pathway in these cells.
Interestingly, MyD88-MACROPHAGE MACROPHAGEON BMDCs  were  also  able  to
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produce comparable levels of these cytokines as wt BMDCs (Fig.3A), indicating that
recombination of the MyD88 cassette also occurs in this population of myeloid cells.
Subsequently, we analysed the capacity of BMDCs to polarise CD4+ Th cells in vitro.
BMDCs from wt, MyD88-DCON, MyD88-macrophageON or  MyD88OFF mice were infected
overnight with different MOI M. bovis BCG overexpressing the mycobacterial antigen
Ag85B, and then co-cultured for 5 days with P25ktk CD4+ T cells, carrying a specific T cell
receptor that recognises the aa 240-254 of Ag85B bound to I-Ab [47]. MyD88OFF BMDCs
showed an impaired ability to induce Th1 cells as compared to wt BMDCs (Fig.3B), yet Th17
induction was only marginal in all four groups. On the contrary, the capacity of MyD88-DCON
and MyD88- macrophageON BMDCs  to  induce  IFN-? production in the proliferating
CellViolow CD4+ T  cells  was  similar  to  that  of  wt  BMDCs (Fig.3B).  Altogether,  our  results
suggest that MyD88 deficient BMDCs have a defective in vitro capacity to induce
inflammatory cytokines and to polarise Th1 cells.
Reactivation of MyD88 signalling in DCs and macrophages restores IL-12p40 and IFN-?
production in vivo
To determine whether reactivation of MyD88 signalling in CD11c- or LysM-expressing cells
was also sufficient to restore inflammatory cytokine production after mycobacterial infection
in vivo, wt, MyD88-DCON, MyD88- macrophageON or MyD88OFF mice were infected i.v. with
2x106 CFUs M. bovis BCG and 20 days later, IL-12p40, IFN-? and IL-1? analysed in sera and
lung homogenates. Like MyD88-/-, MyD88OFF mice showed lower levels of IL-12p40 and
IFN-? in the lungs and serum compared to wt control mice Reactivation of MyD88 signalling
in CD11c+ or LysM+ cells was sufficient to re-establish both IL-12p40 and IFN-? levels in the
lungs, while in serum, MyD88- macrophage ON mice had slightly reduced IL-12p40 respect to
wt mice (Fig.4A). In turn, production of IL-1? in the lungs was impaired in MyD88OFF mice,
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but recovered to wt levels in MyD88-DCON and MyD88- macrophage ON mice, suggesting that
MyD88 signalling in DCs and macrophages is sufficient to restore innate and adaptive
inflammatory cytokine production.
Furthermore, we also examined the adaptive immune response after M. bovis BCG infection
in MyD88OFF mice or mice that have reactivated MyD88 signalling in CD11c+ or  LysM+
cells. We did not find any differences in the percentage or total number of CD4+ and CD8+ T
cells between wt, MyD88-DCON, MyD88- macrophage ON or MyD88OFF infected mice (data
not shown). Moreover, compared to naïve control mice, M. bovis BCG  infection  induces  a
strong increase in the percentage of IFN-?-, but not IL-17A-producing CD4+ T cells in all four
groups  of  mice  (Fig.4B  and  data  not  shown).  Thus,  our  results  suggest  that  the  IFN-?
deficiency observed in MyD88OFF mice was not a consequence of impaired Th1
differentiation.
MyD88 signalling in DCs and M?s is sufficient to control bacterial burden
Finally, we checked whether reactivation of MyD88 signalling in DCs and M?s was
sufficient to protect mice from mycobacterial infection. Mice were infected with 2x106 CFUs
M. bovis BCG and 20 days later, bacterial burden was determined in the lungs, liver and
spleen of  wt, MyD88-DCON, MyD88- macrophage ON or MyD88OFF mice. As shown in
Fig.5A, MyD88OFF exhibited higher bacterial loads than wt mice in all organs examined,
whereas mice that have reactivated MyD88 signalling in myeloid cells (MyD88-DCON or
MyD88- macrophageON) have a similar capacity to eliminate bacteria than wt mice,
independent of the infection doses used (Supporting Information Fig4A). Moreover, whereas
MyD88OFF mice still have increased bacterial burdens in the lungs and liver during the
chronic phase of infection, very low CFUs were detected in MyD88-DCON and MyD88-
macrophageON mice or wt mice (Fig.5B, Supporting Information Fig4B).
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Discussion
MyD88 is an adaptor protein that transduces signals from TIR-containing receptors, such as
IL-1R and  most  TLRs (except  for  TLR3)  [48,  49].  MyD88 is  expressed  in  a  variety  of  cell
types of hematopoietic and non-hematopoietic origin where it can modulate different
inflammatory responses [41, 50-52]. Despite extensive studies on the role of TLRs and
MyD88 in the immune response against mycobacteria, little is known about cell-specific
functions of this key adaptor molecule. In the present study we demonstrate that while
MyD88 complete deficiency leads to chronic M. bovis BCG infection, reconstitution of
MyD88 signalling in DCs and M?s?is sufficient to control bacterial burden.
Innate immune recognition via TLRs has long been considered as a prerequisite for the
initiation and maintenance of cellular adaptive immune responses during infection [53].
However, recent evidence suggests that redundancy in PRRs as well as activation of innate
cells via inflammatory mediators might overcome TLR requirement [54, 55]. Host control of
mycobacteria depends predominantly on Th1 cells and its master regulator, IL-12 [42, 56-58].
Surprisingly, while production of IL-12 and IL-1 by DCs and macrophages in response to
mycobacterial products is MyD88-dependent [40], the relevance of these signalling molecules
for the induction of Th1 and Th17 cells in vivo remains controversial [34, 36, 37, 40]. Here
we show that MyD88-deficient BMDCs are impaired in their  capacity to produce IL-12p40,
TNF? and IL-1? in response to in vitro M. bovis BCG infection and to polarise naïve CD4+ T
cells into IFN-?-producing cells. In vivo, although reduced levels of IL-12p40 and IFN-? were
detected in the sera and lungs of mice lacking MyD88 signalling, a high percentage of IFN-?-
producing CD4+ T cells were found in both MyD88OFF and wt mice, compared to naïve mice.
In addition, similar to the in vitro results, only marginal induction of IL-17A-producing CD4+
T cells could be detected in M. bovis BCG infected mice compared to naïve control mice,
suggesting that IL-17 does not play a significant role in M. bovis BCG infection.  Thus,  our
findings reinforce the role of Th1 responses for the control of mycobacteria, but suggest that a
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sustained systemic and local IL-12/IFN-? production is required for adequate mycobacterial
clearance. Our results in Rag-/- mice and those from others [59] demonstrate that adaptive
immune responses are fundamental for protecting mice against mycobacterial infection. Yet,
the higher bacterial burden observed in MyD88-/- x  Rag-/- mice compared to Rag-/- mice,
suggests that some of the protective mechanisms against mycobacteria depend exclusively on
MyD88 signalling in innate immune cells. Indeed, reactivation of MyD88 signalling in DCs
and macrophages restored IL-12p40 and IFN-? levels in serum and lungs, and protected the
mice from chronic mycobacterial infection. However, whether this is a direct or an indirect
effect on these cells, requires further examination. IL-12p40 can form homodimers and act
independently of p35 in myeloid cells [25], though it is not known if p80 homodimers can
directly induce IFN-? by APCs as it occurs in response to IL-12 and IL-18 [60]. In addition, it
has recently been shown that MyD88 cooperates with IFN-? to fully activate macrophages, a
mechanism required for killing intracellular bacteria [32, 61].
Our  present  study  suggests  that  despite  an  intact  adaptive  immune  response  in  vivo,  the
absence of MyD88 signalling in DCs and macrophages permits mycobacterial persistence.
Similar, previous studies using TLR2 or TLR4 knockout mice show that the absence of TLR
signals leads to a state of chronic infection [37, 62-64]. Chronic mycobacterial infection is
associated with a constant turnover of antigen-specific CD4+ T  cell  [65],  a  process  that
requires  antigen  presentation  as  well  as  IL-12  production  [66].  Recently,  it  has  been  shown
that  DCs  can  enter  and  exit  chronic  granulomas,  suggesting  that  these  cells  might
continuously  sample  mycobacterial  antigen  to  prime T  cells  in  the  LNs  [28].  We could  not
detect any differences in the IFN-?-producing CD4+ T cell responses between MyD88
deficient and wt mice, even at the chronic phase of infection. However, we cannot exclude
that other effector mechanisms of the adaptive immune response are affected.
In humans, primary immunodeficiencies caused by mutations in the MyD88 pathway have
been described [67]. People with defective MyD88 signalling have impaired production of
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 12
pro-inflammatory cytokines and recurrent pyogenic infections, particularly during childhood
[68]. However, contrary to the mouse model, a positive correlation between MyD88 inborn
mutations and susceptibility to tuberculosis could not be established [69]. It is unclear
whether  this  is  due  to  the  low  number  of  patients  affected  by  MyD88-  and  other  related
deficiencies (e.g. IRAK-4 mutations), the fact that many of them die early during childhood as
a consequence of their susceptibility to other infections, or the existence of compensatory
mechanisms for protection against mycobacteria. In this sense, it has been proposed that the
susceptibility of TLR-deficient mice to mycobacterial infection might be influenced by
previous exposure to different housing conditions [36]. In contrast to MyD88 deficiency,
there is consensus that certain mutations in the IL-12/IFN-? axis cause Mendelian
susceptibility to mycobacterial disease (MSMD), a rare syndrome that confers high
predisposition to clinical disease caused by weakly virulent mycobacteria, such as M. bovis
BCG, environmental mycobacteria and also Mtb [70-73]. Clearly, all 6 autosomal mutations
found till date in humans affect IL12/IFN-?-mediated immunity, underlining the importance
of this pathway for protection against Tb.
In conclusion, using new conditional switch-on mouse models, we could demonstrate here
that MyD88 signalling in DCs and macrophages is essential to control bacterial burden during
M. bovis BCG infection. However, further studies will be necessary to dissect the mechanisms
by  which  MyD88  affects  DC versus MACROPHAGE MACROPHAGE function during
mycobacterial disease. CD11c is predominantly expressed in DCs, but also present in alveolar
macrophages??and to a lower extent in activated T cells, NK cells or B cells [74, 75], whereas
Lysozyme M is expressed in macrophages, but also neutrophils and a small fraction of splenic
DCs [46]. Hence, more specific conditional cre lines will be essential to define the importance
of MyD88 in DCs and macrophages for protection against mycobacteria.
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Materials and methods
Mice
Mice expressing MyD88 specifically in CD11c+ or  LysM+ cells (MyD88-DCON or MyD88-
macrophageON)  or  not  (MyD88OFF) were bred and maintained under specific pathogen-free
conditions at the animal facility of the Helmholtz Centre for Infection Research (HZI,
Braunschweig, Germany) or the TWINCORE, Centre for Experimental and Clinical Infection
Research (Hannover, Germany). Furthermore, MyD88-/- and  Rag1-/- mice  and  P25ktk
transgenic mice [47] were used and bred at the same institutions. Sex- and age-matched mice
between 8- and 16-weeks of age were used in all experiments. All animal experiments were
approved by the Veterinary Institute of LAVES (Lower Saxony State Office for Consumer
Protection and Food Safety - Permit number: 10/0075 and 12/0732) considering the German
Animal Welfare Act and all efforts were made to minimise suffering.
Mycobacteria cultures
M. bovis BCG expressing firefly luciferase was kindly provided by Dr. Brian Robertson
(Imperial College London, UK) and M. bovis BCG overexpressing Ag85B (M. bovis BCG-
Ag85B) by Dr. Joel Ernst, (NYU School of Medicine, USA). All strains were grown at 37°C
in Middlebrook 7H9 broth (BD Biosciences) supplemented with 10% Middlebrook OADC
enrichment medium (BD Biosciences), 0.002% glycerol (Roth) and 0.05% Tween-80 (Roth).
Midlog phase cultures were harvested, aliquoted, and frozen at -80°C. For experimental in
vitro infections, M. bovis BCG were prepared as previously described [76]. For in vivo
infections, bacteria were prepared from frozen stocks by thawing at 37°C, resuspension in D-
PBS/0.025% Tween-80 (PBS-T), and passage through a 27 gauge needle.
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In vivo imaging
Mice were infected i.v. with 5x106 CFUs FFluc-BCG and evaluated using an IVIS® Spectrum
CT (PerkinElmer) 5 days later. Prior to assessment of bioluminescence (photons s-1cm-2
steridian (sr)1), mice were anaesthetised using isoflurane (Abbott Laboratories). For the
detection of firefly luciferase activity,  300 mg/kg of D-Luciferin (PerkinElmer) in sterile D-
PBS was administered intraperitoneally (i.p.) 10 min before imaging. Mice were continuously
anesthetised with isoflurane and imaged using the standard-two mice CT option of the IVIS®
Spectrum CT. The CT data were combined with a bioluminescence pseudocolour image
representing light intensity (blue, least intense to red, most intense) by using the Living Image
software (PerkinElmer).
Colony enumeration assay
To determine bacterial burden, mice were infected intravenously (i.v) with approximately
2x106 CFUs of  the  respective M. bovis BCG strain.  At  different  time  points  after  infection,
mice were sacrificed and the lungs, liver and spleen were collected in sterile bags (Nasco)
containing 1mL WTA lysis buffer (0.01% Tween-80 and 0.05% BSA (Roth) in dH20) and
mechanically disrupted. Viable cell counts were determined by plating serial dilutions of the
homogenates on Middlebrook 7H11 agar plates (BD Biosciences) supplemented with 10%
OADC (Difco Laboratories) and 0.5% glycerol (Roth). Plates were incubated at 37°C and
CFUs were enumerated after 3 weeks. Data are presented as log10 CFUs per organ.
DC cytokine secretion assay
For generation of BMDCs, BM cells were prepared from the femurs and tibiae of wt, MyD88-
DCON, MyD88- macrophage ON or MyD88OFF mice, and cultured for 7-8 days in complete
RPMI medium (10% FCS, 10mM Hepes (GIBCO), 50µM ?-mercaptoethanol (GIBCO),
100U/mL penicillin and 100µg/mL streptomycin (Biochrom)) supplemented with 5% culture
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supernatant of a GM-CSF-producing cell line [77]. On day 7-8, 250.000 BMDCs/well were
incubated with M. bovis BCG-Ag85B at different MOI for 5h (the last 3h in the presence of
5µg/mL Brefeldin A (eBioscience)), stained and analysed for intracellular cytokine
production by FACS.
In vitro T-cell proliferation assay
25.000 BMDCs/well were incubated with different MOI M. bovis BCG-Ag85B for 18h,
washed and incubated at a 1:4 ratio with CD4+ T cells,  obtained from the spleen and lymph
nodes of P25ktk mice and enriched by negative magnetic cell sorting using the Dynal Mouse
CD4 negative T cell isolation kit following the manufacturer´s protocol (Life Technologies).
Co-cultures were performed for 5 days in 96-well round bottom plates (Cellstar) in 200µL
complete RPMI medium. Cell proliferation was determined by staining the CD4+P25ktk T
cells with CellTraceViolet Cell Proliferation Kit (Life Technologies) followed by intracellular
staining and FACS analysis.
Flow cytometry
The following antibodies and reagents were purchased from eBioscience: ?CD11c (N418),
?IL-17A (eBio17B7), ?IL-12p40 (C17.8), ?pro-IL-1? (NJTEN3), ?CD4 (GK1.5),
?IFN-? (XMG1.2). ?TNF? (MP6-XT22)  was  purchased  from  R&D  Systems.  To  analyse
intracellular cytokine production by CD4+ T  cells,  1x107 spleen cells were stimulated with
100ng/mL PMA and 1µg/mL Ionomycin for 2h and 5µg/mL Brefeldin A was added for
additional 2-3h before staining. Dead cells were excluded by Aqua fluorescent reactive dye
(Life Technologies) staining. Cellular aggregates were excluded by gating singlets using
SSC-A versus SSC-W. For intracellular cytokine staining, the cells were fixed with 2%
Paraformaldehyde (PFA, Roth) for 20min and permeabilised in PBA-S buffer (0.5% Saponin
and 0.25% BSA, both from Roth in PBS). Data acquisition was performed on a LSRII (BD)
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or a CyAn™ ADP (Beckman Coulter) flow cytometer. Subsequent data analysis was
performed with FlowJo software (Tree Star).
ELISA
Serum  samples  were  collected  and  frozen  at  -80°C  until  analysis.  The  concentration  of  IL-
12p40, IFN-? and IL-1? was determined by ELISA according to the manufacturer’s
instructions (Duo Set, R&D Systems).
Statistical analysis
Unless otherwise stated, data analysis was performed using GraphPad Prism Software version
5.0 (GraphPad Software) and statistics were calculated by comparing groups independently
using unpaired Student t-test. P-values were considered significant as follows: *p<0.05; **p<
0.01; and ***p<0.001.
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Fig.1. MyD88 deficient mice fail to control mycobacterial infection. (A) Mice were
infected i.v. with approximately 5x106 CFUs FFluc-BCG and evaluated using an IVIS®
Spectrum CT imager 5 days later. Left panel shows CT image with co-localisation of FFluc-
BCG luminescence signal in the spleen, lungs and liver of MyD88OFF (left) or wt (right) mice
indicated by white arrows. Right panel depicts a ventral view of one representative mouse per
group of FFluc-BCG luminescence signal. (B) Mice were infected i.v. with approx. 2x106
CFUs M. bovis BCG and bacterial burden in the lungs (left panel) and liver (right panel) of wt
??) and MyD88OFF (?) mice was determined at different days post infection (p.i.). Each
symbol represents one individual mouse. Data are representative of three independent
experiments. Statistic: Two-way ANOVA, Bonferroni post-test. *p<0.05; **p<0.01; and
***p<0.001.
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 27
Fig.2. Mycobacterial control depends on adaptive and MyD88-dependent innate
immune functions. (A) Bacterial burden in the lungs (left panel) and liver (right panel) of wt
??), Rag-/- (?), MyD88-/- (?)  or  MyD88-/- x  Rag-/- (?) mice infected with 2x106 CFUs M.
bovis BCG determined at day 20p.i.. Each symbol represents an individual mouse. Data are
representative of three independent experiments. To calculate statistical significance, samples
from MyD88-/- x Rag-/- mice where the CFUs were too high and could not be counted, were
considered as the highest countable CFUs from the same group. (B) IL-12p40 (left panel),
IFN-???middle panel) and IL-1? (right panel) levels measured by ELISA at day 21 p.i. in the
lungs and serum of wt (?), Rag1-/- (?) or MyD88-/- (?) mice infected i.v. with 2x106 CFUs
M. bovis BCG. Each symbol represents an individual mouse. Data represent the results of one
experiment. Statistics: Student t test. *p<0.05; **p<0.01; and ***p<0.001.
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Fig.3. MyD88 controls cytokine production and Th1 cell polarisation capacity of
BMDCs. (A) Intracellular IL-12p40 (left panel), TNF???middle panel) and IL-1? (right panel)
production by wt (white bars), MyD88-DCON (dark grey bars), MyD88-macrophageON (light
grey bars) or MyD88OFF (black bars) BMDCs infected with different MOI M. bovis BCG or
treated with 1?M CpG-B for 5h. Bar graphs show the mean + SD of triplicate wells. Data are
representative of three independent experiments. (B) Intracellular IFN-???right, upper panel)
and IL-17A (left, lower panel) production by proliferating (CellVioletlow)  P25ktk  CD4+ T
cells co-cultured for 5 days with wt (white bars), MyD88-DCON (dark grey bars), MyD88-
macrophage ON (light grey bars) or MyD88OFF (black bars) BMDCs that were previously
infected with M. bovis BCG  overexpressing  the  Ag85B  at  different  MOI.  FACS  Plots
correspond to an MOI of 5. Bar graphs represent the mean + SD of duplicate wells. Data are
representative of three independent experiments.
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Fig.4. MyD88-signalling controls IL-12p40 and IFN-? production in vivo, but not Th1
differentiation. (A) IL-12p40 (left panel), IFN-???middle panel) and IL-1? (right panel)
levels measured by ELISA at day 20 p.i. in the lungs and serum of wt (?), MyD88-DCON (?),
MyD88-macrophageON (?) or MyD88OFF (?)  mice  infected  i.v.  with  2x106 CFUs M. bovis
BCG. Each symbol represents an individual mouse. Data are pooled from two individual
experiments and are representative of three independent experiments. Statistics: Student t test.
*p<0.05; **p<0.01; and ***p<0.001. (B) Intracellular IFN-? production by spleen CD4+ T
cells from wt (white bars), MyD88-DCON (dark grey bars), MyD88- macrophage ON (light
grey bars) or MyD88OFF (black bars) mice infected i.v. with 2x106 CFUs M. bovis BCG and
analysed  at  day  25  p.i..  Bar  graphs  represent  the  mean  +  SD of  3-6  infected  and  1-4  naïve
mice per group and are representative of three independent experiments.
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Fig.5.  Reactivation of MyD88 in DCs and M?s reduces bacterial  load to wt levels. (A)
Bacterial  burden determined at  day 20 p.i.  in the lungs (left  panel),  liver (middle panel)  and
spleen (right panel) of wt (?), MyD88-DCON (?), MyD88-macrophageON (?) or MyD88OFF
(?) mice infected i.v. with 2x106 CFUs M. bovis BCG. Each symbol represents an individual
mouse. Data are pooled from two individual experiments and are representative of five (lungs,
liver) or two (spleen) independent experiments. (B) Mice were infected i.v. with 2x106 CFUs
M. bovis BCG and bacterial  burden was analysed at  day 60 p.i.  in the lungs (left  panel)  and
liver (right panel) of wt (?), MyD88-DCON (?), MyD88-macrophageON (?) or MyD88OFF
(?) mice. Each symbol represents an individual mouse. Data are pooled from two (lung) or
four (liver) individual experiments. Statistics: Student t test; *p<0.05; **p<0.01; and
***p<0.001.
